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Introduction
Familial Mediterranean fever (FMF) is an autosomal
recessive disease that is prevalent among eastern Mediter-
ranean populations, mainly non-Ashkenazi Jews, Arme-
nians, Turks, and Arabs. Arthritis seen in FMF patients is
generally acute monoarthritis which predominantly affect-
ing the lower limbs, and it occurs during attack periods
and also is a common clinical manifestation in patients
with FMF alike Rheumatoid arthritis (RA). Anti-cyclic
citrullinated peptide (anti-CCP) antibodies testing is use-
ful in the diagnosis of Rheumatoid arthritis with high
specificity. The citrulline residues are essential part of the
antigenic determinants recognized by the RA antibodies.
Objectives
The aim of the study was to show the presence of anti-
cyclic citrullinated peptide (anti-CCP) antibodies in
child individuals diagnosed with Familial Mediterranean
Fever (FMF).
Methods
The study group was comprised of one hundred and
twenty six patients diagnosed with FMF (female/male
(n):66/60); and fifthy healthy control (female/male(n):25/
25) . Clinical and laboratory assessments of the FMF
patients were performed during attack-free periods. Ery-
throcyte sedimentation rate (ESR), serum C-reactive pro-
tein (CRP), fibrinogen and anti-CCP antibody levels were
measured.
Results
Anti-CCP results were negative in healthy controls and
also in all FMF patients. There was not a significant dif-
ference in anti-CCP between the patient and the control
groups. The patient individuals were divided into four
groups according to genetic mutation analysis. The
groups has been comprised as M694V/M694V(n=26),
M694V/Other(n=38), Other/Other(n=46), Negative
(n=16). No significant difference detected between four
mutation groups and anti-CCP levels. Our study has
shown moderate positive correlations between age
(rs= 0.271; p= 0.0020), duration of illness (rs= 0.331;
p<0.0001), colchicinetherapy (rs= 0.259; p= 0.004) and
anti-CCP levels. Also poor positive correlations between
fibrinogen and anti ccp levels was detected (rs= 0.192;
p= 0.0330). Anti-CCP levels has not shown significance
between patients with or without arthritis(p=0.148).
Conclusion
In conclusion, no published data in children establish
anti-CCP values in patients with FMF compared with
healthy controls. Our data show that anti-CCP antibo-
dies are not associated with FMF. Anti-CCP does not
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